Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
Agency: Centers for Disease Control - NCEZID
Assistance Listings: 93.084 -- Prevention of Disease, Disability, and Death by Infectious Diseases
Last Updated: May 21, 2026
Description
The purpose of this NOFO is to improved awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding. The NOFO strategies are to 1) SHARE - Formation of a network of AGS professionals to disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response. 2) EDUCATE - Create AGS communications...
targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, outdoor workers, etc.). Create communications targeted at healthcare providers including educational resources and training. 3) TRACK - Conduct active or enhances public health surveillance for AGS. This strategy could involve patient populations or geographical locations with limited access to specialized healthcare provider care.
Eligibility
Eligible applicants
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Government
- Special district governments
- State governments
- Federally recognized Native American tribal governments
- County governments
- City or township governments
- Public and Indian housing authorities
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
Miscellaneous
- Unrestricted
Business
- For-profit organizations other than small businesses
- Small businesses
Additional information
Bona fide agents are eligible to apply. For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located at https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2
Grantor contact information
Description
Jeff Borchert
gqx1@cdc.gov
gqx1@cdc.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| ck-26-0193_forPublication.pdf | ck-26-0193_forPublication.pdf | May 19, 2026 07:16 PM UTC |
Link to additional information
--
Closing: June 19, 2026
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Award
$10,000,000
Program Funding
3
Expected awards
$25,000
Award Minimum
$1,000,000
Award Maximum
Funding opportunity number:
CDC-RFA-CK-26-0193
Cost sharing or matching requirement:
No
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
--
Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
2
Posted date:
May 19, 2026
Archive date:
July 19, 2026
